Pemetrexed Injection is generally used to treat acute lymphocytic leukemia, which is a biological agent for tumor treatment and can help cancer patients fight against tumors. The main component of pemetrexed injection is pemetrexed, which is effective in the treatment of lymphoma. However, there are certain contraindications for the use of pemetrexed injection, and it cannot be used in patients with hypertension, congenital heart disease, diabetes, etc. The main function and effect of pemetrexed injection is to be used for the first-line treatment of children with acute lymphocytic leukemia. Foreign data suggest that it can also be used to treat adult acute lymphocytic leukemia, non-Hodgkin's lymphoma (NK/T lymphoma, pre-T lymphocyte lymphoma). Pemetrexed injection is effective in the treatment of lymphoma. Lymphoma is a malignant tumor originating from the lymphatic hematopoietic system, mainly manifested as painless lymphadenectasis, hepatomegaly and splenomegaly. All tissues and organs of the body can be affected, accompanied by fever, night sweats, weight loss, itching and other systemic symptoms. The side effects of pemetrexed injection may include lumps and mild pain at the injection site or intravenous injection site after intramuscular or intravenous infusion. These symptoms will gradually disappear after drug withdrawal. The contraindicated population for pemetrexed injection includes patients with chronic diseases such as hypertension, congenital heart disease, diabetes, liver disease, kidney disease, etc., who should use the drug under the guidance of a doctor.
